seed
Stage
2019
Founded
1
Investors
About
Abolis is a synthetic biology company that develops and produces sustainable ingredients for various industries. They leverage cutting-edge synthetic biology and metabolic engineering to create novel microbial strains for high-value compounds.
Explore Abolis's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.